While technically not a pure GLP-1 agonist, tirzepatide produces substantial weight loss (1520%) and marked metabolic improvements, with emerging evidence of significant hepatic fat reduction
Both TRT and BPC-157 require medical supervision
You have options
Currently, the only treatment that has been shown to be effective in MASLD is a weight loss of 710%, which improves histologic fibrosis and steatosis 7
Energy & Wellness Supports energy, recovery, and overall wellness from nutrient depletion
Over the following weeks, well gradually increase your dose until you reach the maximum dose of 2.4 mg, which has been shown to have positive effects on medical conditions such as fatty liver, heart disease, cholesterol levels, high blood pressure, and nonalcoholic steatohepatitis